Reports for ALLERGAN INC

Company Name

ALLERGAN INC

Totals

Shortage reports

75

Actual shortage: 2 (3%)
Anticipated shortage: 1 (1%)
Avoided shortage: 3 (4%)
Resolved: 69 (92%)

Discontinuation Reports

5

To be discontinued: 0 (0%)
Discontinued: 5 (100%)
Reversed: 0 (0%)

Late reports

9 (11%)

Overdue reports

1 (33%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RAPAFLO 4MG CAPSULE Resolved 2018-07-20 2018-09-25 56121
RAPAFLO 8MG CAPSULE Resolved 2019-09-16 2019-10-26 93953
RESTASIS MULTIDOSE 0.05% EMULSION Resolved 2019-02-01 2020-03-19 74356
TAZORAC 0.05% GEL Resolved 2018-11-01 2019-05-18 65978
TAZORAC 0.1% GEL Resolved 2018-11-02 2018-12-01 66125
TAZORAC 0.1% GEL Actual shortage 2020-06-16 2020-07-28 118029
TAZORAC 0.05% CREAM Resolved 2018-11-02 2018-12-01 66116
TAZORAC 0.05% CREAM Resolved 2019-09-16 2019-11-08 93944
TAZORAC 0.1% CREAM Resolved 2019-09-16 2020-03-10 93947
VIIBRYD 10MG TABLET Resolved 2019-01-15 2019-02-28 72344
VIIBRYD 10MG TABLET Resolved 2019-02-28 2019-05-14 77159
VIIBRYD 20MG TABLET Resolved 2019-01-15 2019-05-09 72342
VIIBRYD 20MG TABLET Resolved 2019-05-25 2019-06-07 84782
ZYMAR 0.3% SOLUTION Resolved 2017-08-03 2017-10-13 18241
ZYMAR 0.3% SOLUTION Resolved 2017-12-18 2019-09-19 33440

Showing 61 to 75 of 75

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALOCRIL 2% LIQUID Discontinued 2018-11-28 2019-04-02 67803
ASACOL 400MG TABLET (ENTERIC-COATED) Discontinued 2020-07-31 2020-07-31 121616
BETAGAN 0.5% OPHTHALMIC SOL 5MG LIQUID Discontinued 2020-03-10 2020-03-10 108380
BETAGAN OPH SOLN 0.25% 0.25% LIQUID Discontinued 2017-08-04 2017-08-04 18275
BLEPHAMIDE S.O.P. 0.2% 10% OINTMENT Discontinued 2019-07-31 2019-07-31 90343